PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Columbia University launches Center for Precision Psychiatry & Mental Health with $75 million grant from the Stavros Niarchos Foundation

Columbia University launches Center for Precision Psychiatry & Mental Health with $75 million grant from the Stavros Niarchos Foundation
2023-04-25
(Press-News.org) NEW YORK, April 24, 2023—Columbia University today announced the establishment of the Stavros Niarchos Foundation (SNF) Center for Precision Psychiatry & Mental Health at Columbia University. The center will catalyze the scientific innovation and clinical implementation of precision medicine to advance the prevention, diagnosis, and treatment of mental illness. The center is being established with a $75 million grant from the Stavros Niarchos Foundation (SNF), an international philanthropic organization, as part of SNF’s Global Health Initiative (GHI). 

The SNF Center is a joint effort of the Department of Psychiatry at Columbia University Vagelos College of Physicians and Surgeons and Columbia’s Zuckerman Mind Brain Behavior Institute. It will be embedded within Columbia University’s unique ecosystem of research and clinical services and will draw upon expertise from the Columbia-affiliated New York Genome Center and the New York State Office of Mental Health.

The increasing sophistication of precision medicine is allowing scientists and health care providers to integrate each person’s unique genomic, physiologic, and health profiles to create optimized prevention and treatment strategies. Columbia University has been at the forefront of recent efforts to elucidate the genetic and biological changes that cause a multitude of severe mental illnesses. The SNF Center for Precision Psychiatry & Mental Health will build upon and expand this knowledge by accumulating massive datasets of genomic sequences and longitudinal medical records.  At the same time, by harnessing interdisciplinary expertise from biologists to clinicians, the center will enable the rapid advent, from bench to bedside, of new therapeutic and prevention approaches based upon defined etiologies shared by distinct subgroups of patients.

“The insights provided by genomics and precision medicine are proving of tremendous value in improving people’s health and lives,” said Columbia University President Lee C. Bollinger. “Through this new center, our researchers will meet an urgent human need by harnessing precision medicine to promote mental health for all. We are enormously grateful to the Stavros Niarchos Foundation for joining with Columbia in meeting this profound scientific and humanitarian challenge.”

“The significant progress we have made in caring for our physical health in recent decades is apparent, but just as clear is the fact that we have left behind our mental health,” said SNF Co-President Andreas Dracopoulos. “All of us at SNF are proud to support the doctors, scientists, and mental health professionals at Columbia in bringing together deep expertise with an equally deep sense of humanity to address one of the most critical issues of our time.”

The collaboration between Columbia and SNF arose from a joint vision for helping to reduce the individual and societal toll of mental illness and to combat social inequality, stigma, and discrimination in mental health care. The ecosystem of knowledge and practice at Columbia University brings together research and clinical services and connects the public and private sectors. By driving innovation in mental health research and sharing advances as widely as possible, Columbia and SNF will work to help ensure that improved treatments are equally available to everyone. 

“Many existing treatments in psychiatry do not get at root causes,” said Katrina Armstrong, MD, Chief Executive Officer of Columbia University Irving Medical Center and Dean of the Faculties of Health Sciences at the Vagelos College of Physicians and Surgeons. “We welcome this opportunity to develop new approaches that focus on disease mechanisms and target treatment based on an individual’s unique genetic makeup and biology for the ultimate benefit of lifting up care for the community at large.”

Among the major projects of the SNF Center is the Genomic Medicine for Mental Health Advancement (GeMMA) initiative, being conducted in close collaboration with the New York Genome Center (NYGC). Tom Maniatis, PhD, Evnin Family Scientific Director and CEO of the NYGC and Isidore Edelman Professor of Biochemistry and Molecular Biophysics at Columbia, said, “The GeMMA initiative will not only provide essential information for individual patients, it will also build upon and expand pioneering work at Columbia University central to establishing ‘causal’ relationships between genetic variation and brain function, which is a critical step in the development of new approaches to diagnosis, treatment, and prevention of mental illness.”

The New York State Office of Mental Health (OMH) is a major partner of the SNF Center with a renowned reputation as one of the largest and most innovative learning public mental healthcare systems in the nation. OMH Commissioner Ann Sullivan, MD said, “The Stavros Niarchos Foundation Center for Precision Psychiatry & Mental Health ushers in an entirely new era of mental health care through the unprecedented potential for integration of precision psychiatry into standard clinical practice. OMH is proud to partner with Columbia University on this transformative mission, and we are deeply grateful to SNF for their remarkable commitment to improving mental health worldwide.”

The center will be co-directed by Sander Markx, MD, assistant professor of clinical psychiatry at Columbia’s Vagelos College of Physicians and Surgeons (VP&S) and director of the Center for Precision Neuropsychiatry at the New York State Psychiatric Institute; Steven A. Kushner, MD, PhD, professor of psychiatry at VP&S and a principal investigator at the New York State Psychiatric Institute; and Joseph Gogos, MD, PhD, professor of physiology & cellular biophysics, neuroscience, and psychiatry at VP&S and a principal investigator at Columbia’s Zuckerman Mind Brain Behavior Institute, who together conveyed their collective vision for the center: “With this extraordinary support from SNF, we are poised to build on the accelerating progress in psychiatric genomics, neuroscience, artificial intelligence, and stem cell biology to revolutionize the treatment of mental illness. Through this new understanding, we are fundamentally committed to helping combat stigma and discrimination against people living with mental illness and realizing improved mental health care for all.”

 

About the Stavros Niarchos Foundation (SNF)

The Stavros Niarchos Foundation (SNF) is one of the world’s leading private, international philanthropic organizations, making grants to nonprofit organizations in the areas of arts and culture, education, health and sports, and social welfare. SNF funds organizations and projects worldwide that aim to achieve a broad, lasting, and positive impact for society at large, and exhibit strong leadership and sound management. The Foundation also supports projects that facilitate the formation of public-private partnerships as an effective means for serving the public welfare. 

Since 1996, the Foundation has committed over $3.5 billion through more than 5,200 grants to nonprofit organizations in over 130 countries around the world. The ongoing $750 million-plus Global Health Initiative (GHI) is SNF’s largest-ever grant initiative. It includes the design, construction and outfitting of three new hospitals in Greece, procurement of critical equipment such as air ambulances, training programs for health care providers, efforts to expand access to quality mental health care such as the Child and Adolescent Mental Health Initiative in Greece, and collaborations with institutions like The Rockefeller University, the Child Mind Institute, and the National Children’s Alliance in the United States; Sant Joan de Déu Barcelona Children’s Hospital; King Hussein Cancer Foundation and Center in Jordan; and Yorkshire Cancer Research in the United Kingdom.

See more at snf.org.

 

About Columbia University

Among the world’s leading research universities, Columbia University in the City of New York continually seeks to advance the frontiers of scholarship and foster a campus community deeply engaged in understanding and confronting the complex issues of our time through teaching, research, patient care and public service. The Department of Psychiatry at Columbia University Vagelos College of Physicians and Surgeons is among the top-ranked psychiatry departments in the nation and has made major contributions to the understanding and treatment of psychiatric disorders. For almost a century, the department has collaborated with the New York State Office of Mental Health’s Psychiatric Institute, an international leader in understanding mental health and mental illness. Columbia is also home to the Zuckerman Institute, a renowned neuroscience research center that pioneers urgently needed insights into mind, brain and behavior that benefit health and society.

 

####

 

END


[Attachments] See images for this press release:
Columbia University launches Center for Precision Psychiatry & Mental Health with $75 million grant from the Stavros Niarchos Foundation Columbia University launches Center for Precision Psychiatry & Mental Health with $75 million grant from the Stavros Niarchos Foundation 2

ELSE PRESS RELEASES FROM THIS DATE:

Research links common insecticide to neurodevelopmental disorders

Research links common insecticide to neurodevelopmental disorders
2023-04-25
A new study from The University of Toledo suggests early exposure to a common class of insecticides called pyrethroids may increase the risk of autism and other developmental disorders, even at levels currently recognized as safe by federal regulators. The findings, which come from a study of mice, were published today in the peer-reviewed journal PNAS Nexus. Pyrethroids are some of the most widely used insecticides in the country, appearing in both consumer products and industrial preparations. “If ...

New research sheds light on how to choose quality eHealth tools

2023-04-25
With so many eHealth tools available, it can be challenging to select the best one for a specific health need. A recent study published in JMIR Human Factors provides valuable insights on how to choose quality eHealth tools in an evolving landscape of digital health technology. This study titled “Assessing the Quality and Impact of eHealth Tools: Systematic Literature Review and Narrative Synthesis” comprehensively examined how the quality and impact of eHealth tools are currently assessed. Led by Dr Christine Jacob, a health tech researcher at the University of Applied Sciences and Arts Northwestern ...

SwRI tests automated vehicles in virtual off-road environments

SwRI tests automated vehicles in virtual off-road environments
2023-04-25
SAN ANTONIO – April 25, 2023 – Southwest Research Institute (SwRI) has created a 3D simulation tool to test automated vehicles in virtual off-road environments modeled after real-world conditions. The research expands SwRI’s investment into software-in-the-loop solutions to test connected and automated vehicles (CAVs) in scenarios ranging from congested roadways to off-road terrain. A simulated environment, or a 3D “software loop,” supports evaluations of an infinite number of scenarios that would be cost-prohibitive to test in the real world. The technology meets U.S. Department of Defense demands ...

Pesticides and neurodevelopment disorders

Pesticides and neurodevelopment disorders
2023-04-25
A study of 72 mice mothers and their litters suggests a popular pesticide may cause neurodevelopmental disorders in humans. Previous studies have shown that nearly half of the risk for neurodevelopment disorders, including autism, is environmental, but few specific environmental causes have been clearly identified. James Burkett and colleagues exposed mice to low doses of  pyrethroid pesticide deltamethrin during pregnancy and lactation. Pups of exposed mothers vocalized less compared to pups of unexposed mothers. ...

HRD detection predicts sensitivity to platinum-based chemotherapy for ovarian cancer patients in China - BGI Insight

HRD detection predicts sensitivity to platinum-based chemotherapy for ovarian cancer patients in China - BGI Insight
2023-04-25
Homologous Recombination Deficiency (HRD) is a biomarker that predicts ovarian cancer treatment with PARP inhibitors or breast cancer treatment with first-line platinum-based chemotherapy. However, limited research is documented on platinum-based treatment prediction with HRD as a biomarker in ovarian cancer patients, especially in the Chinese population. This first-ever China prospective cohort study, jointly conducted by BGI Genomics clinical researcher Dr. Shao Di and the Fudan University Shanghai Cancer Center team and published on the Journal of Ovarian ...

NIAID appoints Ted Pierson as new Vaccine Research Center director

NIAID appoints Ted Pierson as new Vaccine Research Center director
2023-04-25
“Ted brings a wealth of knowledge and expertise in virology and human immune responses to viruses. He has played a key role in developing antiviral vaccines and furthering our understanding of important viruses transmitted by mosquitoes and ticks—arboviruses—and how neutralizing antibodies work against flaviviruses, such as Zika virus,” said Acting NIAID Director Hugh Auchincloss, M.D. “He is exceptionally well-suited to lead the VRC and its continued pursuit of innovative basic, translational and clinical discovery.”   Prior to his VRC appointment, Dr. Pierson served as a senior investigator and chief of NIAID’s Laboratory of ...

Ten grants totalling $1 million awarded to support the future of clinical stroke research

2023-04-25
Brain Canada, Heart & Stroke, and the Canadian Stroke Consortium are thrilled to announce the recipients of the 2022 Stroke Clinical Research Catalyst Grants. The purpose of this program is to increase capacity for clinical stroke research within Canada, with an aim to reduce the burden of stroke, prevent recurrence, and improve patient outcomes through clinical research that will improve our understanding of stroke and advance stroke care. “We are thrilled to be collaborating with two leading organizations ...

Cartesian Therapeutics announces appointment of three world-renowned scientists and engineers as charter members of company's scientific advisory board

Cartesian Therapeutics announces appointment of three world-renowned scientists and engineers as charter members of companys scientific advisory board
2023-04-25
Gaithersburg, MD; April 25, 2023 - Cartesian Therapeutics, a fully integrated biopharmaceutical company pioneering RNA cell therapy for autoimmune diseases and cancer, today announced the appointment of three world-renowned scientists and engineers as charter members of the company’s Scientific Advisory Board (SAB): Prof. Jennifer Elisseeff (Johns Hopkins University), Prof. Andrés García (Georgia Institute of Technology), and Prof. David Mooney (Harvard University). “These distinguished research leaders bring vast ...

Study shows promising results for immunotherapy targeting skin cancer

2023-04-25
A new class of immunotherapy shows promising results for fighting the most aggressive form of skin cancer. The study, published today in Nature Communications by researchers from King’s College London and Guy’s and St Thomas’ NHS Foundation Trust, investigates whether a novel antibody can target and treat melanomas. The results show that the antibody activates the immune response to fight cancer and slows melanoma growth in mice. Malignant melanoma is the most aggressive type of skin cancer with poor ...

How do you define shyness? A new study analyzes shyness in children

2023-04-25
What is shyness? Research has shown that shyness is characterized by fear and nervousness in response to social novelty and/or social evaluation. Shyness can manifest on behavioral, affective, and physiological levels, but little is known about how these components cluster. Longstanding theories note that shyness may be conceptualized as a trait that is relatively stable across development, which is described as temperamental shyness. Shyness may also be conceptualized as an emotion that is felt in a certain social situation, which is described as state shyness. To ...

LAST 30 PRESS RELEASES:

Research proves stool DNA as non-invasive alternative for colorectal cancer screening in Thailand

Detecting evidence of lung cancer in exhaled breath

A joint research team of Korea University College of Medicine announced the world's first single-port robotic thymectomy comparative results

National Mental Health Institute awards CAD 45 million to develop mental health treatments 

Washington coast avian flu outbreak devastated Caspian terns, jumped to seals

Mice tails whip up new insights into balance and neurodegenerative disease research

New study: Earthquake prediction techniques lend quick insight into strength, reliability of materials

Vitamin D during pregnancy boosts children’s bone health even at age seven

Use of “genetic scissors” carries risks

Does work-related stress compromise cardiovascular health?

New research may lead to potatoes that are less reliant on nitrogen fertilizers

Do commercial ties influence ESG ratings?

Study assesses "gendered space" in financial institutions in Pakistan

Chinese herbal medicine’s potential in preventing dementia

Firms that read more perform better

Tightly tied waist cord of saree underskirt may pose cancer risk, warn doctors

10% of children in high-burden tuberculosis settings may develop the disease by age 10

Health experts push for the elimination of a ‘remarkably harmful toxin’

University of Tennessee, Lockheed Martin expand Master Research Agreement

Testing thousands of RNA enzymes helps find first ‘twister ribozyme’ in mammals

Groundbreaking study provides new evidence of when Earth was slushy

International survey of more than 1600 biomedical researchers on the perceived causes of irreproducibility of research results

Integrating data from different experimental approaches into one model is challenging – this study presents a community-based, full-scale in silico model of the rat hippocampal CA1 region that integra

SwRI awarded grant to characterize Las Moras Springs watershed

Water overuse in MATOPIBA could mean failure to meet up to 40% of local demand for crop irrigation

An extra year of education does not protect against brain aging

Researchers from Uppsala and Magdeburg obtain an ERC Synergy Grant to advance cancer immunotherapy

Deaf male mosquitoes don’t mate

Recognizing traumatic brain injury as a chronic condition fosters better care over the survivor’s lifetime

SwRI’s Dr. James Walker receives Distinguished Scientist Award from Hypervelocity Impact Society

[Press-News.org] Columbia University launches Center for Precision Psychiatry & Mental Health with $75 million grant from the Stavros Niarchos Foundation